US.HUM · Humana

{
  "risk": {
    "level": "Elevated",
    "reason": "risk management score >= 5/10",
    "position": {
      "score": 1.3,
      "details": {
        "atrPct": 3.570682010135135,
        "turnoverUsdM": 433.287168,
        "liquidityPoints": 0.6,
        "volatilityPoints": 0.7
      }
    },
    "rrPoints": 1.4,
    "stopLevels": {
      "symbol": "US.HUM",
      "rr_range": "1:1.0-1:2.5",
      "risk_profile": "中等",
      "stop_loss_price": 351.8228,
      "strength_details": {
        "ma_score": 1,
        "atr_score": 1,
        "rsi_score": 2,
        "macd_score": 1.5,
        "volume_score": 1
      },
      "market_adjustment": 1,
      "risk_reward_ratio": 1,
      "stop_loss_percent": 7.1,
      "take_profit_price": 398.0004,
      "target_multiplier": 1.6,
      "technical_strength": 1.33,
      "take_profit_percent": 5
    },
    "positionPoints": 1.3,
    "stopLossPoints": 1.2,
    "diversification": {
      "score": 2,
      "details": {
        "method": "sector concentration proxy; no portfolio holdings used",
        "sector": "Health Care",
        "concentratedSectorPenalty": 0
      }
    },
    "riskRewardRatio": 1.2,
    "stopLossPercent": 7.14136402027027,
    "diversificationPoints": 2
  },
  "total": {
    "max": 160,
    "result": 56.1,
    "formula": "score_with_momentum_v2 = main_score + momentum_5d_v2_score",
    "baseScore": 53.1,
    "modelVersion": "cursor_18_27_news_v2_160",
    "momentum5dScore": 3
  },
  "market": {
    "ma20": 377.191,
    "ma50": 383.2498,
    "close": 378.88,
    "prevClose": 380.73,
    "avgVolume20": 1426085,
    "volumeRatio": 0.8,
    "changePercent": -0.49
  },
  "sources": {
    "catalyst": "finnhub_news_keyword_model",
    "sentiment": "finnhub_news_keyword_model",
    "fundamentals": "fmp_stable",
    "institutional": null,
    "marketContext": "twelvedata+fred"
  },
  "barCount": 60,
  "momentum": {
    "max": 50,
    "result": 3,
    "details": {
      "ret_5d": -0.026140568856668378,
      "max_score": 50,
      "max_total": 50,
      "raw_total": 3,
      "vcp_bonus": 0,
      "vol_ratio": 0.8134175486514169,
      "ret_points": 0,
      "vol_points": 0,
      "range_ratio": 0.609762746413817,
      "volat_points": 0,
      "day_range_pct": 0.024678024704391885,
      "model_version": "cursor_18_27_news_v2_160",
      "available_bars": 30,
      "breakout_points": 0,
      "partial_history": false,
      "pullback_points": 3,
      "breakout_vol_bonus": 0,
      "first_breakout_20d": false,
      "return_window_days": 5,
      "first_breakout_bonus": 0,
      "breakout_quality_points": 0
    },
    "formula": "Cursor_18.25 5D momentum v2 0-50",
    "modelVersion": "cursor_18_27_news_v2_160"
  },
  "scoreMax": 110,
  "composite": {
    "max": 160,
    "result": 56.1,
    "formula": "Cursor_18.25 ranking score v2 (score_with_momentum_v2)",
    "weights": [
      {
        "raw": 2.9,
        "label": "基本面",
        "weight": "5/110",
        "normalized": 58,
        "contribution": 2.9
      },
      {
        "raw": 10.8,
        "label": "資金流",
        "weight": "20/110",
        "normalized": 54,
        "contribution": 10.8
      },
      {
        "raw": 9.8,
        "label": "市場環境",
        "weight": "15/110",
        "normalized": 65.33,
        "contribution": 9.8
      },
      {
        "raw": 2,
        "label": "催化劑",
        "weight": "20/110",
        "normalized": 10,
        "contribution": 2
      },
      {
        "raw": 5.9,
        "label": "風險管理",
        "weight": "10/110",
        "normalized": 59,
        "contribution": 5.9
      },
      {
        "raw": 17.7,
        "label": "技術信號",
        "weight": "30/110",
        "normalized": 59,
        "contribution": 17.7
      },
      {
        "raw": 4,
        "label": "情緒分析",
        "weight": "10/110",
        "normalized": 40,
        "contribution": 4
      }
    ],
    "modelVersion": "cursor_18_27_news_v2_160"
  },
  "momentumMax": 50,
  "scoreStatus": "checked",
  "standard110": {
    "rating": "避免",
    "result": 53.1,
    "details": [
      "基本面分析總分: 2.9/5分",
      "資金流分析總分: 10.8/20分",
      "市場環境分析總分: 9.8/15分",
      "催化劑分析: 2/20分",
      "風險管理總分: 5.9/10分",
      "技術信號分析總分: 17.7/30分",
      "情緒分析: 4/10分",
      "共振率(僅顯示不加分): 0%"
    ],
    "formula": "基本面5 + 資金流20 + 市場環境15 + 催化劑20 + 風險管理10 + 技術信號30 + 情緒10",
    "dimensionScores": {
      "催化劑": 2,
      "基本面": 2.9,
      "資金流": 10.8,
      "市場環境": 9.8,
      "情緒分析": 4,
      "技術信號": 17.7,
      "風險管理": 5.9
    },
    "dimensionDetails": {
      "催化劑": {
        "max": 20,
        "grade": "較差",
        "items": {
          "catalyst": {
            "score": 2,
            "details": {
              "source": "finnhub_news_keyword_model",
              "articleCount": 8,
              "catalystCount": 0
            }
          },
          "catalystPoints": 2
        }
      },
      "基本面": {
        "max": 5,
        "grade": "較差",
        "items": {
          "pbPoints": 0.5,
          "pePoints": 0.2,
          "epsPoints": 0,
          "roePoints": 0,
          "debtPoints": 0.5,
          "marginPoints": 0,
          "turnoverUsdM": 433.287168,
          "volumePoints": 0.5,
          "revenuePoints": 0.4,
          "dividendPoints": 0.3,
          "marketCapPoints": 0.5
        },
        "source": "fmp_stable"
      },
      "資金流": {
        "max": 20,
        "grade": "較差",
        "items": {
          "cmfPoints": 0.8,
          "mfiPoints": 2.4,
          "obvPoints": 1.6,
          "vwapPoints": 4,
          "institutional": {
            "score": 2,
            "details": {
              "source": "optional-neutral",
              "warning": {
                "code": "INSTITUTIONAL_DATA_OPTIONAL",
                "symbol": "US.HUM",
                "message": "Institutional ownership is unavailable; neutral 2/4 money-flow treatment used."
              },
              "optional": true,
              "holderCount": null,
              "holderPoints": 2,
              "top10ShareRatio": null,
              "concentrationPenalty": 0
            }
          },
          "institutionPoints": 2
        }
      },
      "市場環境": {
        "max": 15,
        "grade": "一般",
        "items": {
          "vix": {
            "score": 2.4,
            "details": {
              "source": "twelvedata+fred",
              "vixClose": 16.01
            }
          },
          "trend": {
            "score": 3,
            "details": {
              "qqq": {
                "ma20": 709.1885013500001,
                "ma50": 713.4416018399997,
                "name": "QQQ",
                "close": 713.44,
                "points": 1
              },
              "spy": {
                "ma20": 762.32700215,
                "ma50": 751.7496043999998,
                "name": "SPY",
                "close": 765.71997,
                "points": 2
              },
              "source": "twelvedata+fred"
            }
          },
          "atrPct": 3.570682010135135,
          "atrPoints": 2,
          "cciPoints": 2.4,
          "vixPoints": 2.4,
          "marketTrendPoints": 3
        }
      },
      "情緒分析": {
        "max": 10,
        "grade": "較差",
        "items": {
          "sentiment": {
            "score": 4,
            "details": {
              "source": "finnhub_news_keyword_model",
              "articleCount": 8,
              "negativeHits": 0,
              "positiveHits": 3,
              "sentimentScoreRaw": 0.9
            }
          },
          "sentimentData": {
            "raw": [
              {
                "id": 141282114,
                "url": "https://finnhub.io/api/news?id=820709aa611f7e2d444c90205003d9baa63032bbdcbe5f4fc8534097fa1b2af0",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q2. Today, we are looking at health insurance providers stocks, starting with Humana (NYSE:HUM).",
                "category": "company",
                "datetime": 1787171162,
                "headline": "Q2 Earnings Highlights: Humana (NYSE:HUM) Vs The Rest Of The Health Insurance Providers Stocks"
              },
              {
                "id": 141282108,
                "url": "https://finnhub.io/api/news?id=1f32201175d72dc5503106155ed2358732e02164e69a600a6d6ef9a4584a206e",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "Humana (HUM) is back on investors’ radar after a strong earnings beat, fresh quality gains in its insurance operations, new caregiver retention initiatives in Indiana, and a leadership hire to oversee its Medicaid unit. See our latest analysis for Humana. Humana’s recent earnings beat and operational gains have come alongside strong price momentum, with a 27.5% 90 day share price return and 47.1% year to date share price return, although the 3 year total shareholder return is still down...",
                "category": "company",
                "datetime": 1786835348,
                "headline": "Humana (HUM) Beats On Earnings And Quality, Is The Stock Above Fair Value?"
              },
              {
                "id": 141154806,
                "url": "https://finnhub.io/api/news?id=cc9ecb3a04070c81dd895f711030a759aa5e1af03b6597f0c29559920560d32f",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "CEO Rechtin details Medicare Advantage margin recovery strategy through 2028.",
                "category": "company",
                "datetime": 1786147362,
                "headline": "Humana (HUM) Q2 2026 Earnings Call Transcript"
              },
              {
                "id": 141153836,
                "url": "https://finnhub.io/api/news?id=4b67b627834160de394269ad32e0d12b704490e7f4833444b29bd07a49062e94",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "In late July 2026, Humana reported higher second-quarter revenue of US$40,867 million and net income of US$694 million, while also confirming completion of a US$276.13 million share repurchase program initiated in February 2024 and announcing two new board appointments, Paul Smith and Frederick Crawford. Despite stronger quarterly results and governance additions, Humana lowered its full-year 2026 GAAP EPS guidance to at least US$6.52 from at least US$8.36, signaling a more cautious outlook...",
                "category": "company",
                "datetime": 1786140784,
                "headline": "Humana (HUM) Is Up 5.8% After Cutting 2026 EPS Outlook Amid Strong Q2 And Buybacks"
              },
              {
                "id": 141119935,
                "url": "https://finnhub.io/api/news?id=2034771c9082037d6d21a7b0170b6cebba3550e89f0d603121d48aa0547afa2f",
                "image": "",
                "source": "Fintel",
                "related": "HUM",
                "summary": "",
                "category": "company",
                "datetime": 1785924895,
                "headline": "Morgan Stanley Upgrades Humana (HUM)"
              },
              {
                "id": 141111996,
                "url": "https://finnhub.io/api/news?id=d1b9e985cfbf86d9491591349ab8be0fb4e189ec74e39d2230ae79da9d17d645",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "Hotchkis & Wiley, an investment management company, released its second-quarter 2026 investor letter for the “Hotchkis & Wiley Mid-Cap Value Fund.” A copy of the letter can be downloaded here. Equity markets posted strong returns in the second quarter of 2026, with the Russell Midcap Index rising 13.8% and the Russell Midcap Value Index returning 13.4%, […]",
                "category": "company",
                "datetime": 1785859496,
                "headline": "Humana’s (HUM) Path to Recovery and Growth"
              },
              {
                "id": 141106814,
                "url": "https://finnhub.io/api/news?id=c136eac7cb6dcec81c7ec3ad7123f4cb2f3adf14472f6f87f1437f31bc9aac18",
                "image": "",
                "source": "Fintel",
                "related": "HUM",
                "summary": "",
                "category": "company",
                "datetime": 1785830393,
                "headline": "Humana (HUM) Price Target Increased by 34.49% to 416.50"
              },
              {
                "id": 141103200,
                "url": "https://finnhub.io/api/news?id=6e39cdcb8ac7039719accc0814b1ec3a48efae4d250a3db47be83384c645ac7a",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "Diamond Hill Capital, a First Eagle Investment Management company, issued its Q2 2026 investor letter for its “Large Cap Strategy”. A copy of the letter is available to download here. The Strategy returned 3.42% net of fees, trailing the Russell 1000 Value Index’s 13.87% gain. Performance benefited from stock selection in consumer staples, materials and consumer discretionary, along with an underweight in utilities. However, stock […]",
                "category": "company",
                "datetime": 1785766963,
                "headline": "Is Humana (HUM) an Undervalued Turnaround Play as Medicare Margins Recover?"
              }
            ],
            "raw_source": [
              {
                "id": 141278437,
                "url": "https://finnhub.io/api/news?id=b295eac02aec9c6a14a41b24daf8c516e0e5d52cc2f5cdffb36783e0ac4015ed",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "The healthcare giant is wrestling with costs in one part of its business, and the stock's recent dip has investors wondering if this is the moment to step in.",
                "category": "company",
                "datetime": 1787349486,
                "headline": "Is The Pullback In UNH Stock A Glitch Or A Warning?"
              },
              {
                "id": 141278439,
                "url": "https://finnhub.io/api/news?id=0aa4c6eab65e8fa1fe312f6d5ad967c837c98714d3987241138d505991dec443",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "UNH is prioritizing Medicare Advantage profitability over membership growth, using tighter benefits, pricing and cost controls to improve margins.",
                "category": "company",
                "datetime": 1787333520,
                "headline": "Is UnitedHealth Finding a Better Path to Medicare Advantage Growth?"
              },
              {
                "id": 141278449,
                "url": "https://finnhub.io/api/news?id=984f68cae88b01dc0468fddba0bc7fb289ae283fd6a8aabceb2bf6c887b1fa62",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "HUM's Star Ratings recovery is set to show early progress, but October's CMS release will test its MA turnaround and path to a 2028 margin target.",
                "category": "company",
                "datetime": 1787244420,
                "headline": "Can Humana's Star Ratings Rebound Unlock MA Earnings Power?"
              },
              {
                "id": 141282105,
                "url": "https://finnhub.io/api/news?id=28519a00412e241ddc0b2316680245d23eb0d09c3525c47e7239048511f5e594",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "LOUISVILLE, Ky., August 20, 2026--Humana Inc. (NYSE: HUM) today announced that Shantanu Nundy, M.D., will join the company as Chief Medical Officer, effective August 31. A practicing physician, healthcare executive, and technology leader, Dr. Nundy has spent his career using technology to make care better, simpler, and more human. At Humana, he will bring an innovative clinical voice to the enterprise and help shape the design of the company's products, platforms, and use of AI. Dr. Nundy will r",
                "category": "company",
                "datetime": 1787227200,
                "headline": "Humana Names Dr. Shantanu Nundy as Chief Medical Officer"
              },
              {
                "id": 141278441,
                "url": "https://finnhub.io/api/news?id=8bbcb50138decae38ed578ff993643f02aee591f40024bde3c1e02dc3746f399",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "Dr. Shantanu Nundy is joining the Kentucky-based insurer from health navigation firm Accolade. He’s had a varied career — advising the FDA on AI, teaching, working for the World Bank, practicing medicine and more.",
                "category": "company",
                "datetime": 1787223843,
                "headline": "Humana taps physician executive as new chief medical officer"
              },
              {
                "id": 141282114,
                "url": "https://finnhub.io/api/news?id=820709aa611f7e2d444c90205003d9baa63032bbdcbe5f4fc8534097fa1b2af0",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q2. Today, we are looking at health insurance providers stocks, starting with Humana (NYSE:HUM).",
                "category": "company",
                "datetime": 1787171162,
                "headline": "Q2 Earnings Highlights: Humana (NYSE:HUM) Vs The Rest Of The Health Insurance Providers Stocks"
              },
              {
                "id": 141258963,
                "url": "https://finnhub.io/api/news?id=a415fc07907197a7f9360b6450ff2edea764c2626a17877f0e266de5b3e9d0aa",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "UNH's improving medical costs, higher EPS estimates and capital returns support its recovery, but regulatory risks remain.",
                "category": "company",
                "datetime": 1787159760,
                "headline": "UnitedHealth Stock Looks Reasonable at 18.39X P/E: Should You Buy Now?"
              },
              {
                "id": 141279621,
                "url": "https://finnhub.io/api/news?id=ef88b4db26a94236c2ae97c48e671e7ae0ad4893bd5dd000ee89f002e99fba0c",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "Costco stock reclaimed a key technical level on Tuesday as the warehouse club climbed amid news of a partnership to offer Medicare Advantage plans to members.  Costco Wholesale will offer co-branded plans in partnership with nonprofit health insurer Scan Group.  Scan, based in Long Beach, Calif., has about 560,000 Medicare Advantage members in Southern California, Arizona, Nevada, New Mexico and Texas, according to the Wall Street Journal.",
                "category": "company",
                "datetime": 1787080732,
                "headline": "Costco Stock Sets Up Amid Medicare Advantage News"
              },
              {
                "id": 141275095,
                "url": "https://finnhub.io/api/news?id=e2b4a279455a0776b0ea8407e9fd95a06396fdacb37c0bf034bbb91f2ce65e6e",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "Joel Greenblatt built Gotham Asset Management on concentrated value bets, so his latest 13F filing caught analysts off guard with moves that look less like a stock-picker's conviction and more like someone quietly bracing for impact.",
                "category": "company",
                "datetime": 1787069545,
                "headline": "Billionaire Joel Greenblatt’s 5 Biggest Moves This Quarter Reveal a Surprising Defensive Shift"
              },
              {
                "id": 141244705,
                "url": "https://finnhub.io/api/news?id=be80c4cb30856d289d827b5c8223d809a45988346066920470f0734de8ace71d",
                "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1345765699/image_1345765699.jpg?io=getty-c-w1536",
                "source": "SeekingAlpha",
                "related": "HUM",
                "summary": "In an ongoing trend, many leading managed care insurers saw shifts in membership, notably in the senior-focused, government-subsidized Medicare Advantage plans.",
                "category": "company",
                "datetime": 1787028060,
                "headline": "U.S. Health Insurers Raise Outlooks Despite Q2 Cost Rises, Shifting Membership"
              },
              {
                "id": 141239729,
                "url": "https://finnhub.io/api/news?id=ccd2ea8851c0b4b01e6bcf4847b75690ef0993697f38657d9476c66c127a9022",
                "image": "https://cdn.benzinga.com/files/images/story/2025/11/06/aggregated_options_3.jpg?width=2048&height=1536",
                "source": "Benzinga",
                "related": "HUM",
                "summary": "This whale alert can help traders discover the next big trading opportunities.\nWhales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scanner.\nTraders often",
                "category": "company",
                "datetime": 1786973716,
                "headline": "4 Health Care Stocks With Whale Alerts In Today’s Session"
              },
              {
                "id": 141231125,
                "url": "https://finnhub.io/api/news?id=20166a2b2acd2263cfdbcc99fc419c59e514054bea615fc73fdbae8d84095aeb",
                "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1445262091/image_1445262091.jpg?io=getty-c-w1536",
                "source": "SeekingAlpha",
                "related": "HUM",
                "summary": "Healthcare sector valuation check: equipment undervalued, providers near baseline, pharma/biotech overvalued. Learn more about IHF ETF here.",
                "category": "company",
                "datetime": 1786867596,
                "headline": "IHF: Healthcare Dashboard For August"
              },
              {
                "id": 141282108,
                "url": "https://finnhub.io/api/news?id=1f32201175d72dc5503106155ed2358732e02164e69a600a6d6ef9a4584a206e",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "Humana (HUM) is back on investors’ radar after a strong earnings beat, fresh quality gains in its insurance operations, new caregiver retention initiatives in Indiana, and a leadership hire to oversee its Medicaid unit. See our latest analysis for Humana. Humana’s recent earnings beat and operational gains have come alongside strong price momentum, with a 27.5% 90 day share price return and 47.1% year to date share price return, although the 3 year total shareholder return is still down...",
                "category": "company",
                "datetime": 1786835348,
                "headline": "Humana (HUM) Beats On Earnings And Quality, Is The Stock Above Fair Value?"
              },
              {
                "id": 141282107,
                "url": "https://finnhub.io/api/news?id=7aff55b5f5de8d973ca510bea2c5d3a1197cd15c3ea42df1850b1548a943a85d",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "Medicare Advantage plans are shrinking. Here's what to expect and what to do if your plan is affected.",
                "category": "company",
                "datetime": 1786810079,
                "headline": "Why Medicare Advantage providers are cutting plans — and what to do if your coverage is affected"
              },
              {
                "id": 141282118,
                "url": "https://finnhub.io/api/news?id=55c6cf6839d622f1222ed890eaef8ee35bb0c40910e48a031dd342c5a3f03253",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "Yahoo Finance Senior Columnist Kerry Hannon explains that major health insurers like Humana (HUM) and UnitedHealth Group (UNH) are dropping hundreds of thousands of Medicare Advantage members to protect profit margins as rising utilization drives up costs.",
                "category": "company",
                "datetime": 1786745500,
                "headline": "Humana, UnitedHealth trim Medicare Advantage on rising costs"
              },
              {
                "id": 141282109,
                "url": "https://finnhub.io/api/news?id=9da0e6529107690ffecf54e4ad8404bf485527182e5ce0fbe90c1ce587e80eee",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "A Humana termination letter looks like bad news, but it quietly unlocks a set of rights most members never knew they had, and those rights expire on a clock most people never see coming.",
                "category": "company",
                "datetime": 1786744941,
                "headline": "Humana Is Dropping Plans That Cover 600,000 Medicare Members in 2027. The Letters Arrive in September."
              },
              {
                "id": 141282110,
                "url": "https://finnhub.io/api/news?id=26f3bd4a0cc5d8341430a64371ccae3e8494cbc2c7b4ae42fe6c5da462a62ab0",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "Humana has outperformed the broader market over the past year, and analysts are moderately optimistic about the stock’s prospects.",
                "category": "company",
                "datetime": 1786707416,
                "headline": "Do Wall Street Analysts Like Humana Stock?"
              },
              {
                "id": 141216543,
                "url": "https://finnhub.io/api/news?id=8f90b1bf8a8ca0e19a08ee253d27540cd211eeea879286163b5557b466f1392d",
                "image": "https://cdn.benzinga.com/files/images/story/2026/08/14/Los-Angeles---Jan-8-Mark-Cuban-At-The-Sp.jpg?width=2048&height=1536",
                "source": "Benzinga",
                "related": "HUM",
                "summary": "Mark Cuban is urging funds to divest from major health insurers. Here’s how broad-market ETFs remain exposed to the companies he’s targeting.",
                "category": "company",
                "datetime": 1786700896,
                "headline": "Mark Cuban Wants Investors Out of Health Insurers. That’s Tough If You Own These ETFs"
              },
              {
                "id": 141212158,
                "url": "https://finnhub.io/api/news?id=7730b8ebf9b742cb0c5a753f4df1250af1c36bbe10f7ecea337020be3c81ade8",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "Management had named the plan exits, the Medicare margin target and the repricing date before the run began.",
                "category": "company",
                "datetime": 1786657819,
                "headline": "The Signs Before UnitedHealth Stock Ran Were In Its Own Exit Plan"
              },
              {
                "id": 141210847,
                "url": "https://finnhub.io/api/news?id=42e28496e7f2ad2a5db1e407f5aca83207b3828c59271f2bb0658ea61a3ce6d4",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "Management has raised its full-year earnings outlook twice, and the segment doing most of the lifting is still short of its own target margin.",
                "category": "company",
                "datetime": 1786655397,
                "headline": "CVS Health Stock's Next Leg Sits In Aetna's Unfinished Margin Repair"
              },
              {
                "id": 141206528,
                "url": "https://finnhub.io/api/news?id=36b24b9c3cd2bcb170d4b9cb46edc04af33246eae0a534d75da78a3d291365a0",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "HUM's HealthStream deal backs 1,000 caregiver scholarships and new tools to improve recruitment and retention in Indiana.",
                "category": "company",
                "datetime": 1786630620,
                "headline": "Can Humana Improve Caregiver Retention With HealthStream Deal?"
              },
              {
                "id": 141202148,
                "url": "https://finnhub.io/api/news?id=000d7e0864da19bcf78c19a4a2c1c87a425ea45a4576641bcde07ad3d7e985f2",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "CVRx (NASDAQ:CVRX) outlined its efforts to expand adoption of its Barostim therapy for heart failure patients, emphasizing sales-force execution, payer coverage progress and a large post-market clinical trial during Canaccord Genuity’s 46th Annual Growth Conference. President and CEO Kevin Hykes sa",
                "category": "company",
                "datetime": 1786604530,
                "headline": "CVRx Eyes Barostim Growth as Coverage Gains and BENEFIT-HF Trial Launches"
              },
              {
                "id": 141203899,
                "url": "https://finnhub.io/api/news?id=189125c65d2ebcacca14cb777c1c68971d225165806b5eb0196a097a06b428b1",
                "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2230767136/image_2230767136.jpg?io=getty-c-w1536",
                "source": "SeekingAlpha",
                "related": "HUM",
                "summary": "Key contributors include Texas Instruments, Humana, and Nucor. Click here to read more.",
                "category": "company",
                "datetime": 1786597200,
                "headline": "Diamond Hill Large Cap Fund Q2 2026 Portfolio Update"
              },
              {
                "id": 141202149,
                "url": "https://finnhub.io/api/news?id=4d387feb582c8384d67af085ca88eb4d4e7e802a2724dfb25ca07b31628d2a94",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "Older adults could be scrambling for new health coverage next year, especially in rural markets that have fewer insurance choices.",
                "category": "company",
                "datetime": 1786471320,
                "headline": "Health insurers are dumping Medicare Advantage plans. Here’s how many seniors could be affected."
              },
              {
                "id": 141202150,
                "url": "https://finnhub.io/api/news?id=a7419a676d2fe7eb8c1d433f60b72ca17cd1234cc2ac0be3bf54ed44a4a01df6",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "INDIANAPOLIS, August 11, 2026--Humana Healthy Horizons in Indiana Collaborates with HealthStream to Expand and Strengthen Home Care Workforce",
                "category": "company",
                "datetime": 1786449600,
                "headline": "Humana Healthy Horizons in Indiana Collaborates with HealthStream to Expand and Strengthen Home Care Workforce"
              },
              {
                "id": 141184476,
                "url": "https://finnhub.io/api/news?id=5c664ace9461239246208baaf33273ada87c46e96745dfdabd12f6412a0c0bb9",
                "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2178335816/image_2178335816.jpg?io=getty-c-w1536",
                "source": "SeekingAlpha",
                "related": "HUM",
                "summary": "Equity markets posted strong returns during the second quarter, with robust corporate earnings and a resilient domestic economy supporting investor sentiment. Read more here.",
                "category": "company",
                "datetime": 1786441500,
                "headline": "Diamond Hill Mid Cap Fund Q2 2026 Contributors And Detractors"
              },
              {
                "id": 141202151,
                "url": "https://finnhub.io/api/news?id=0430b1b5ba821a9a0752eb3fe62e2106529922dc04f05cb8905f9fa7e3f0e2a1",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "James “J.P.” Holland is taking the reins of Humana’s Medicaid business, a key growth area for the company, starting this coming Monday. It’s part of a broader leadership transition announced late last year.",
                "category": "company",
                "datetime": 1786438226,
                "headline": "Humana taps ex-Johns Hopkins exec as Medicaid leader"
              },
              {
                "id": 141184788,
                "url": "https://finnhub.io/api/news?id=ae2bb843f1f9e99dca127f357933c6c758b8933eb937c5bfa96078361b9984de",
                "image": "https://cdn.benzinga.com/files/images/story/2026/08/11/Los-Angeles---Jan-8-Mark-Cuban-At-The-Sp.jpg?width=2048&height=1536",
                "source": "Benzinga",
                "related": "HUM",
                "summary": "Mark Cuban urged investors to pressure health insurers over healthcare costs, calling for funds to divest their stakes.",
                "category": "company",
                "datetime": 1786422511,
                "headline": "Mark Cuban Urges Investors to Pressure Health Insurers Over Healthcare Costs: ‘You Can Make a Difference’"
              },
              {
                "id": 141177794,
                "url": "https://finnhub.io/api/news?id=08481e31fac281e2165fe5c71787fea1f4387660394dab8fb73566a99f9b12c2",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "LOUISVILLE, Ky., August 10, 2026--Humana Inc. (NYSE: HUM) today announced that James \"J.P.\" Holland will join the company as senior vice president and President of Medicaid, effective August 17. In this role, Holland will lead the company’s growing Medicaid business, which currently serves more than 1.6 million members in 11 states. Holland will report to Aaron Martin, President of Insurance.",
                "category": "company",
                "datetime": 1786385700,
                "headline": "James P. Holland to Join Humana as Medicaid President"
              },
              {
                "id": 141186021,
                "url": "https://finnhub.io/api/news?id=28202e72c8c8b3b4cd6ec26c627d8f71c3e388ce40b632b0de65941db639ce83",
                "image": "",
                "source": "Benzinga",
                "related": "HUM",
                "summary": "JP Morgan  analyst Lisa Gill   maintains Humana (NYSE:HUM) with a Neutral and raises the price target from $316 to $393.",
                "category": "company",
                "datetime": 1786372206,
                "headline": "JP Morgan Maintains Neutral on Humana, Raises Price Target to $393"
              },
              {
                "id": 141154806,
                "url": "https://finnhub.io/api/news?id=cc9ecb3a04070c81dd895f711030a759aa5e1af03b6597f0c29559920560d32f",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "CEO Rechtin details Medicare Advantage margin recovery strategy through 2028.",
                "category": "company",
                "datetime": 1786147362,
                "headline": "Humana (HUM) Q2 2026 Earnings Call Transcript"
              },
              {
                "id": 141153836,
                "url": "https://finnhub.io/api/news?id=4b67b627834160de394269ad32e0d12b704490e7f4833444b29bd07a49062e94",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "In late July 2026, Humana reported higher second-quarter revenue of US$40,867 million and net income of US$694 million, while also confirming completion of a US$276.13 million share repurchase program initiated in February 2024 and announcing two new board appointments, Paul Smith and Frederick Crawford. Despite stronger quarterly results and governance additions, Humana lowered its full-year 2026 GAAP EPS guidance to at least US$6.52 from at least US$8.36, signaling a more cautious outlook...",
                "category": "company",
                "datetime": 1786140784,
                "headline": "Humana (HUM) Is Up 5.8% After Cutting 2026 EPS Outlook Amid Strong Q2 And Buybacks"
              },
              {
                "id": 141152483,
                "url": "https://finnhub.io/api/news?id=5797addd1addc6df73a852eee2c2cd2d23ae1c10fa4a572980ba53e8fe9de20f",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "In the health insurance arena, one company is both the undisputed leader and the most expensive ticket, forcing investors to decide if paying up for quality is a winning strategy.",
                "category": "company",
                "datetime": 1786135201,
                "headline": "UNH Leads Its Peer Group. You Pay For That"
              },
              {
                "id": 141149476,
                "url": "https://finnhub.io/api/news?id=a2c5fc5099420119934b83a9a6e73adc3e13dff50b20f53e835dbac7c6783601",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "Alignment Healthcare raises its 2026 outlook as membership and medical-cost trends improve, but heavier second-half investments could pressure near-term profitability.",
                "category": "company",
                "datetime": 1786117860,
                "headline": "Can ALHC's Raised 2026 Outlook Offset Heavier Second-Half Spending?"
              },
              {
                "id": 141147399,
                "url": "https://finnhub.io/api/news?id=739d81ec862e312fb6c60ec026fc62c399a71713b055e1c11749640312c93eb5",
                "image": "https://cdn.benzinga.com/files/images/story/2026/08/07/Stock-Market-Crash-Background-With-Falli.jpg?width=2048&height=1536",
                "source": "Benzinga",
                "related": "HUM",
                "summary": "CVRx stock sinks after hours after lowering full-year revenue outlook despite revenue growth.",
                "category": "company",
                "datetime": 1786066923,
                "headline": "CVRx Stock Is Falling Overnight: Here's What's Driving the Move"
              },
              {
                "id": 141142867,
                "url": "https://finnhub.io/api/news?id=c5563122402addef1e93f2a8c44f06e66869fdf8277ea40fb6766f3913e2c3d4",
                "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1417147459/image_1417147459.jpg?io=getty-c-w1536",
                "source": "SeekingAlpha",
                "related": "HUM",
                "summary": "The Diamond Hill Small-Mid Cap Fund rose 9.71% in Q2 2026. Read the full analysis for details on portfolio moves and top contributors.",
                "category": "company",
                "datetime": 1786050600,
                "headline": "Diamond Hill Small-Mid Cap Fund Q2 2026 Portfolio Review"
              },
              {
                "id": 141140772,
                "url": "https://finnhub.io/api/news?id=c312152e49e1581bc885a555c812314da89407467a6515aef5f78d938d335033",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "MINNEAPOLIS, Aug. 06, 2026 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX) (\"CVRx\"), a commercial-stage medical device company focused on developing, manufacturing and commercializing innovative neuromodulation solutions for patients with cardiovascular diseases, today announced its financial and operating results for the second quarter of 2026. Recent Highlights Total revenue for the second quarter of 2026 was $15.7 million, an increase of approximately 16% over the prior year quarterU.S. revenue",
                "category": "company",
                "datetime": 1786046700,
                "headline": "CVRx Reports Second Quarter 2026 Financial and Operating Results"
              },
              {
                "id": 141135476,
                "url": "https://finnhub.io/api/news?id=b554468778e5c095ddc3f193f1e45eb705550cc81179ff4de4f6f99fc236c5e1",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "Alignment Healthcare lifted its 2026 outlook after 31%+ membership and revenue growth, but rich earnings valuation and second-half risks may justify a wait-and-see approach.",
                "category": "company",
                "datetime": 1786027440,
                "headline": "Is ALHC Stock a Buy as Fast Growth Clashes With Premium Valuation?"
              },
              {
                "id": 141124226,
                "url": "https://finnhub.io/api/news?id=5b6f0956188068f745ee45976b72540b207bf00c682395f6f0b21b550c1e5902",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "UnitedHealth's revenue held up; the operating margin on it did not, and closing that gap is the whole upside case.",
                "category": "company",
                "datetime": 1785945015,
                "headline": "The Case For UnitedHealth Stock Is Margin, Not Growth"
              },
              {
                "id": 141131709,
                "url": "https://finnhub.io/api/news?id=c35b0e71051bf1b59089d8205ab1c57ac9d3424a6516c7513df12b962208c851",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "Equity-Insider.com News Commentary - There is a class of mining milestone that does not generate the same excitement as a drill result or a construction start, but without which neither of those events can proceed on schedule. Land access specifically, the orderly, legally prescribed, community-endorsed process of compensating landholders for the ground a mine will occupy is one of them. When it goes wrong, mines stall. Permitting is challenged. Community relationships fracture. Projects that lo",
                "category": "company",
                "datetime": 1785938640,
                "headline": "Community Trust Is a Mine-Building Tool. LVG Just Used It to Unlock the Final Land Parcel at Imwelo."
              },
              {
                "id": 141122425,
                "url": "https://finnhub.io/api/news?id=12db69f9cdafe0ff2686b26b189d80dad081635d4359a46491954e6398f22fb1",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "(Bloomberg) -- CVS Health Corp. shares fell after the company gave preliminary 2027 profit guidance that disappointed investors and warned of challenges in its pharmacy benefit manager next year, overshadowing a better-than-expected second quarter report.Most Read from BloombergTrump Says Iran Talks Going Well as Hopes Rise for Hormuz DealSpaceX’s AI Splurge Puts Damper on Debut Earnings After IPOChina’s AI Blitz Creates ‘Death Zone’ for Rival US Model MakersTaco Bell Met With Michigan on Parasi",
                "category": "company",
                "datetime": 1785937308,
                "headline": "CVS Falls After Preliminary 2027 Guidance Disappoints"
              },
              {
                "id": 141121252,
                "url": "https://finnhub.io/api/news?id=38c809292d0fa1861866c62a77931f6b3b386365a6f7d37c95073de73061be0d",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "Best Buy downgraded, Bristol Myers upgraded: Wall Street's top analyst calls",
                "category": "company",
                "datetime": 1785937236,
                "headline": "Best Buy downgraded, Bristol Myers upgraded: Wall Street's top analyst calls"
              },
              {
                "id": 141121414,
                "url": "https://finnhub.io/api/news?id=b6f3124f8d1c945448ff560741132e25e718a897fdd107151f1c34248e153358",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "LOUISVILLE, Ky., August 05, 2026--Humana Subsidiary iCare Selected for Family Care and Family Care Partnership Contracts Across Southeast Wisconsin",
                "category": "company",
                "datetime": 1785931200,
                "headline": "Humana Subsidiary iCare Selected for Family Care and Family Care Partnership Contracts Across Southeast Wisconsin"
              },
              {
                "id": 141120623,
                "url": "https://finnhub.io/api/news?id=5698cf584578f1ab4444f8c59972b66ece84d0b5b8b2f53b293b58b22d52468d",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "Wall Street analysts reshuffled their ratings on Wednesday, sending some familiar names higher while punishing others with sharp target cuts. Find out which stocks got surprise upgrades and which ones analysts are now walking away from.",
                "category": "company",
                "datetime": 1785931171,
                "headline": "Here Are Wednesday’s Top Wall Street Analyst Research Calls: Archer-Daniels Midland, Best Buy, Burlington Stores, Dell Technologies, e.l.f. Beauty, Humana, Transdigm, Vale, and More"
              },
              {
                "id": 141119935,
                "url": "https://finnhub.io/api/news?id=2034771c9082037d6d21a7b0170b6cebba3550e89f0d603121d48aa0547afa2f",
                "image": "",
                "source": "Fintel",
                "related": "HUM",
                "summary": "",
                "category": "company",
                "datetime": 1785924895,
                "headline": "Morgan Stanley Upgrades Humana (HUM)"
              },
              {
                "id": 141126469,
                "url": "https://finnhub.io/api/news?id=9b5b5245590db8fdf1034407a99c28675af2c9440edb791e664d166b3b7a09fd",
                "image": "",
                "source": "Benzinga",
                "related": "HUM",
                "summary": "Independent Care Health Plan (iCare), a Humana subsidiary, has been selected by the Wisconsin Department of Health Services to serve both the Family Care and Family Care Partnership programs in the greater southeast",
                "category": "company",
                "datetime": 1785917046,
                "headline": "Independent Care Health Plan Selected By Wisconsin Department Of Health Services For Family Care, Family Care Partnership Programs"
              },
              {
                "id": 141121800,
                "url": "https://finnhub.io/api/news?id=aa8ab40c4a83a1b97cecdf700cf5041ccd40313e18ed2ddc5bd91a086946c5a4",
                "image": "https://cdn.benzinga.com/files/images/story/2026/08/05/Stuttgart--Germany---07-28-2023-Person-H.jpg?width=2048&height=1536",
                "source": "Benzinga",
                "related": "HUM",
                "summary": "Top Wall Street analysts changed their outlook on top names. See analyst ratings page for complete view. Check out what analysts think of HUM stock.",
                "category": "company",
                "datetime": 1785916539,
                "headline": "This Humana Analyst Is No Longer Bearish; Here Are Top 5 Upgrades For Wednesday"
              },
              {
                "id": 141126471,
                "url": "https://finnhub.io/api/news?id=455cc16f9c2e263f51f27b3aee34bf04b52eb4c3c6b3be0a39f2071ab158c682",
                "image": "",
                "source": "Benzinga",
                "related": "HUM",
                "summary": "Morgan Stanley  analyst Erin Wright   upgrades Humana (NYSE:HUM) from Underweight to Equal-Weight and raises the price target from $249 to $370.",
                "category": "company",
                "datetime": 1785908022,
                "headline": "Morgan Stanley Upgrades Humana to Equal-Weight, Raises Price Target to $370"
              },
              {
                "id": 141115048,
                "url": "https://finnhub.io/api/news?id=0f593dfa6708c76223cc458f52b7a88f0cb7454eaa06b5b23c545901111990b4",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "AdaptHealth Corp (AHCO) navigates a transformative quarter with diabetes divestiture and Humana expansion, despite facing significant contract and pricing challenges.",
                "category": "company",
                "datetime": 1785877387,
                "headline": "AdaptHealth Corp (AHCO) (Q2 2026) Earnings Call Highlights: Strategic Pivots and Headwinds ..."
              },
              {
                "id": 141112773,
                "url": "https://finnhub.io/api/news?id=014a623496be595444b2cd0b07829ee26470d3fd42a2b03f046b0558238ac22f",
                "image": "https://www.chartmill.com/images/uploads/CM_Top_Movers_Small_free_2b4ff2fc22.webp",
                "source": "ChartMill",
                "related": "HUM",
                "summary": "Let's have a look at the top S&P500 gainers and losers one hour before the close of the markets of today's session.",
                "category": "company",
                "datetime": 1785870301,
                "headline": "These S&P500 stocks are moving in today's session"
              },
              {
                "id": 141111996,
                "url": "https://finnhub.io/api/news?id=d1b9e985cfbf86d9491591349ab8be0fb4e189ec74e39d2230ae79da9d17d645",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "Hotchkis & Wiley, an investment management company, released its second-quarter 2026 investor letter for the “Hotchkis & Wiley Mid-Cap Value Fund.” A copy of the letter can be downloaded here. Equity markets posted strong returns in the second quarter of 2026, with the Russell Midcap Index rising 13.8% and the Russell Midcap Value Index returning 13.4%, […]",
                "category": "company",
                "datetime": 1785859496,
                "headline": "Humana’s (HUM) Path to Recovery and Growth"
              },
              {
                "id": 141108860,
                "url": "https://finnhub.io/api/news?id=f3c0a9f251f0a1626647be7f98b08d111d7989205e9995cc42f588644084a8b0",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "LOUISVILLE, Ky., August 04, 2026--Humana Inc. (NYSE: HUM) today announced Humana Community Day 2026, its annual nationwide day of service taking place Wednesday, Aug. 26, 2026, mobilizing thousands of employees to volunteer in communities across the United States.",
                "category": "company",
                "datetime": 1785844800,
                "headline": "Humana Community Day 2026 Mobilizes Thousands of Employees Nationwide to Support Healthier Communities"
              },
              {
                "id": 141106814,
                "url": "https://finnhub.io/api/news?id=c136eac7cb6dcec81c7ec3ad7123f4cb2f3adf14472f6f87f1437f31bc9aac18",
                "image": "",
                "source": "Fintel",
                "related": "HUM",
                "summary": "",
                "category": "company",
                "datetime": 1785830393,
                "headline": "Humana (HUM) Price Target Increased by 34.49% to 416.50"
              },
              {
                "id": 141102940,
                "url": "https://finnhub.io/api/news?id=4994f47996da2987119a207d9803c9d7f3e2e6f926e9e2c819982339354579ac",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "The company published the arithmetic of its own margin repair, and the first hard proof landed a quarter before the shares started compounding.",
                "category": "company",
                "datetime": 1785788221,
                "headline": "CVS Health Stock Surged On An Aetna Recovery That Management Had Already Sized"
              },
              {
                "id": 141103200,
                "url": "https://finnhub.io/api/news?id=6e39cdcb8ac7039719accc0814b1ec3a48efae4d250a3db47be83384c645ac7a",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "Diamond Hill Capital, a First Eagle Investment Management company, issued its Q2 2026 investor letter for its “Large Cap Strategy”. A copy of the letter is available to download here. The Strategy returned 3.42% net of fees, trailing the Russell 1000 Value Index’s 13.87% gain. Performance benefited from stock selection in consumer staples, materials and consumer discretionary, along with an underweight in utilities. However, stock […]",
                "category": "company",
                "datetime": 1785766963,
                "headline": "Is Humana (HUM) an Undervalued Turnaround Play as Medicare Margins Recover?"
              },
              {
                "id": 141101154,
                "url": "https://finnhub.io/api/news?id=75c4ff9468184490f9be59f115fe9957f2f06de90bdd7d9d9254ceb47be7b3ed",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "Major Medicare Advantage insurer Humana is withdrawing from certain markets for 2027, a move expected to be mirrored by other companies facing rising medical expenses.",
                "category": "company",
                "datetime": 1785672000,
                "headline": "Thousands Of Seniors May Lose Medicare Advantage As Plan Exits Escalate"
              },
              {
                "id": 141089083,
                "url": "https://finnhub.io/api/news?id=942b569e9d8b0c5ddc0d20e55dcc11e756324533600d1b97f4610b89aa90f822",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "Health insurance company Humana (NYSE:HUM) announced better-than-expected revenue in Q2 CY2026, with sales up 26.2% year on year to $40.89 billion. Its non-GAAP profit of $7.61 per share was 8.8% above analysts’ consensus estimates.",
                "category": "company",
                "datetime": 1785611700,
                "headline": "HUM Q2 Deep Dive: Margin Initiatives, Operational Progress, and Medicare Advantage Strategy"
              },
              {
                "id": 141084913,
                "url": "https://finnhub.io/api/news?id=8005abfcb45e8cdabe4e5a6ed8d85e79f5a6d532b3986d49462703e7dbb6c4ae",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "Humana Inc. said Wednesday it plans to exit additional Medicare Advantage plans in 2027, a move expected to affect about 600,000 members. The insurer said the changes are part of its strategy to improve profitability while reshaping its Medicare Advantage...",
                "category": "company",
                "datetime": 1785551417,
                "headline": "US Insurer Humana Is Exiting More Medicare Advantage Plans in 2027— Here's Who Could Be Affected"
              },
              {
                "id": 141080430,
                "url": "https://finnhub.io/api/news?id=99f8686ad4c4c4632e90f8a6863ecab11fb9e7e11e1844192be7c40ca4fbfa92",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "Humana has elected Paul Smith, Chief Commercial Officer at AI firm Anthropic, to its Board of Directors. The company has also elected Frederick Crawford, formerly President and COO at Aflac, to its Board. Both appointments add technology, insurance and financial expertise at the board level. Humana, traded as NYSE:HUM, is adding additional technology and insurance leadership at a time when its stock has seen a mix of gains and setbacks. The share price is $366.66, with the stock up 38.6%...",
                "category": "company",
                "datetime": 1785514183,
                "headline": "Humana (HUM) Adds Anthropic And Aflac Veterans To Its Board"
              },
              {
                "id": 141078993,
                "url": "https://finnhub.io/api/news?id=20a75c1e9091041914218ad2349141d379e846b8809bc2b23e5f3e9cc9ab55a3",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "Millions of Medicare Advantage members will open a letter this fall that could quietly close doors they assume will always stay open. What insurers have already decided for 2027 and what enrollees do next could cost thousands of dollars or make coverage impossible to find.",
                "category": "company",
                "datetime": 1785510282,
                "headline": "Medicare Advantage Insurers Are Redrawing the Map for 2027. Members Find Out by Letter This Fall."
              },
              {
                "id": 141078994,
                "url": "https://finnhub.io/api/news?id=2b219a3e77c8f6e358fd5153e8682484795f8313cb8697de0c73ce586ddea8a5",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "The lever behind UnitedHealth stock's climb was a Medicare Advantage repricing management had described months before the run began, and the hard part was believing a plan whose author had just been wrong.",
                "category": "company",
                "datetime": 1785508598,
                "headline": "UnitedHealth Stock Ran On A Repricing The Company Described In Advance"
              },
              {
                "id": 141081001,
                "url": "https://finnhub.io/api/news?id=5c6ed25b1bad2426358d995eba05abc81befdb0208e4d772eb5fbf02aa9aa30d",
                "image": "",
                "source": "Benzinga",
                "related": "HUM",
                "summary": "TD Cowen  analyst Ryan Langston   maintains Humana (NYSE:HUM) with a Hold and raises the price target from $350 to $370.",
                "category": "company",
                "datetime": 1785501956,
                "headline": "TD Cowen Maintains Hold on Humana, Raises Price Target to $370"
              },
              {
                "id": 141081002,
                "url": "https://finnhub.io/api/news?id=9e24899c16bd7dbbf9cecbdb80808258d42465b5597f0b914074497058f1c306",
                "image": "",
                "source": "Benzinga",
                "related": "HUM",
                "summary": "Barclays  analyst Andrew Mok   maintains Humana (NYSE:HUM) with a Equal-Weight and raises the price target from $344 to $407.",
                "category": "company",
                "datetime": 1785482911,
                "headline": "Barclays Maintains Equal-Weight on Humana, Raises Price Target to $407"
              },
              {
                "id": 141075465,
                "url": "https://finnhub.io/api/news?id=07faf61c0725136cdc7c75d902d550fa24394c6d7dbee81b30efb1614ef3afd6",
                "image": "",
                "source": "Fintel",
                "related": "HUM",
                "summary": "",
                "category": "company",
                "datetime": 1785474595,
                "headline": "Raymond James Downgrades Humana (HUM)"
              },
              {
                "id": 141075466,
                "url": "https://finnhub.io/api/news?id=5b6897fbb10ba2d610a368747c53f1a0fd3d63452b04b20f71b01914306e1005",
                "image": "",
                "source": "Fintel",
                "related": "HUM",
                "summary": "",
                "category": "company",
                "datetime": 1785474581,
                "headline": "Evercore ISI Group Upgrades Humana (HUM)"
              },
              {
                "id": 141069880,
                "url": "https://finnhub.io/api/news?id=e743bcaa2aa4edb5d0d585c5e3fb6395b0b0971aec2b37db656572d733b99d94",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "Cigna delivers an earnings and revenue beat as Cigna Healthcare fuels growth, while the company raises its 2026 EPS outlook despite higher pharmacy costs.",
                "category": "company",
                "datetime": 1785435420,
                "headline": "CI Q2 Earnings Beat Estimates on Cigna Healthcare Strength"
              },
              {
                "id": 141081003,
                "url": "https://finnhub.io/api/news?id=bf571ea5d63f3c7f0ca6bdeb049a0ec4b97c2c3bbd4e0e088fc13e45b886e8ab",
                "image": "",
                "source": "Benzinga",
                "related": "HUM",
                "summary": "UBS  analyst A.J. Rice   maintains Humana (NYSE:HUM) with a Neutral and raises the price target from $320 to $405.",
                "category": "company",
                "datetime": 1785429538,
                "headline": "UBS Maintains Neutral on Humana, Raises Price Target to $405"
              },
              {
                "id": 141065428,
                "url": "https://finnhub.io/api/news?id=f1a525f7febfe29e36efcf0fff4a6cf3a816c2870472e10e28139f4703f53ba7",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "Humana upgraded, Las Vegas Sands downgraded: Wall Street's top analyst calls",
                "category": "company",
                "datetime": 1785418702,
                "headline": "Humana upgraded, Las Vegas Sands downgraded: Wall Street's top analyst calls"
              },
              {
                "id": 141065653,
                "url": "https://finnhub.io/api/news?id=ba0ba56675ebd129bd3592b52e81b0d1bfd927de4150e65fc32b78363457f15b",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "Shares of health insurance company Humana (NYSE:HUM) fell 7.2% in the afternoon session after the company reported a solid second-quarter earnings beat but was overshadowed by a concerning outlook for future profitability.",
                "category": "company",
                "datetime": 1785414542,
                "headline": "Humana (HUM) Stock Trades Down, Here Is Why"
              },
              {
                "id": 141065476,
                "url": "https://finnhub.io/api/news?id=b5b37993df632720d56a95f4fbec69e9580ba015315fc4466d9f8d74f1a92bb5",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "Wall Street analysts reshuffled their bets on Thursday as geopolitical fires, a Fed dissent surprise, and a brutal semiconductor selloff forced some major rating reversals across insurance, gaming, tech, and energy stocks.",
                "category": "company",
                "datetime": 1785413116,
                "headline": "Here Are Wednesday’s Top Wall Street Analyst Research Calls: Bloom Energy, Dave, Fiverr, Humana, Las Vegas Sands, Lemonade, Procter & Gamble, SK hynix, Wix.com, and More"
              },
              {
                "id": 141067556,
                "url": "https://finnhub.io/api/news?id=46e0a4b476c1902822c24a284d898a0f806f1bfe25b1b64aa2c94c9e2ba633a5",
                "image": "",
                "source": "Benzinga",
                "related": "HUM",
                "summary": "Evercore ISI Group  analyst Elizabeth Suzuki   upgrades Humana (NYSE:HUM) from In-Line to Outperform and raises the price target from $430 to $480.",
                "category": "company",
                "datetime": 1785405275,
                "headline": "Evercore ISI Group Upgrades Humana to Outperform, Raises Price Target to $480"
              },
              {
                "id": 141067557,
                "url": "https://finnhub.io/api/news?id=907166071c5f491c17b1c9b40ac17a48f2a51ec121f291e61068145a22cf34d0",
                "image": "",
                "source": "Benzinga",
                "related": "HUM",
                "summary": "Guggenheim  analyst Jason Cassorla   maintains Humana (NYSE:HUM) with a Buy and raises the price target from $269 to $471.",
                "category": "company",
                "datetime": 1785405014,
                "headline": "Guggenheim Maintains Buy on Humana, Raises Price Target to $471"
              },
              {
                "id": 141067559,
                "url": "https://finnhub.io/api/news?id=803eec13f285fe2c428ed95bdcb13908fcc27fb34bb635b7aba18893b0a37e7d",
                "image": "https://cdn.benzinga.com/files/images/story/2026/07/30/Stuttgart--Germany---07-28-2023-Person-H.jpg?width=2048&height=1536",
                "source": "Benzinga",
                "related": "HUM",
                "summary": "Analysts change outlook on top names, including PAY, MAS, FVRR, HUM, and SITE. See their ratings and price targets on Benzinga's analyst ratings page.",
                "category": "company",
                "datetime": 1785396922,
                "headline": "This Humana Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Thursday"
              },
              {
                "id": 141067560,
                "url": "https://finnhub.io/api/news?id=c5199db518b099c3d52b4dfa621984d4667150957731ea31f8971dcd5598fced",
                "image": "",
                "source": "Benzinga",
                "related": "HUM",
                "summary": "Raymond James  analyst John Ransom   downgrades Humana (NYSE:HUM) from Outperform to Market Perform.",
                "category": "company",
                "datetime": 1785391326,
                "headline": "Raymond James Downgrades Humana to Market Perform"
              },
              {
                "id": 141063004,
                "url": "https://finnhub.io/api/news?id=64a3e6728268b07c8b069aff37de3640980acf165c656d650063807f801743f7",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "Humana (NYSE:HUM) said its 2026 performance is tracking in line with expectations, with management emphasizing planned Medicare Advantage margin expansion in 2027, progress in its Stars program and continued operating-cost reductions as key components of its path toward a sustainable pretax margin o",
                "category": "company",
                "datetime": 1785384236,
                "headline": "Humana Q2 Earnings Call Highlights"
              },
              {
                "id": 141059681,
                "url": "https://finnhub.io/api/news?id=62587334cad4bce3c49d28f358417fda7765be21ed1fd8cd97aaba074c4bb60d",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "Moby summary of Humana Inc.'s Q2 2026 earnings call",
                "category": "company",
                "datetime": 1785363499,
                "headline": "Humana Inc. Q2 2026 Earnings Call Summary"
              },
              {
                "id": 141057198,
                "url": "https://finnhub.io/api/news?id=f8552d103d34c3eed0e03e84cfae9fd81193907771b556811b57571c8ef86b6a",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "Humana Inc (HUM) outlines its strategy for margin growth and operational efficiency amidst planned market exits and cost management initiatives.",
                "category": "company",
                "datetime": 1785351815,
                "headline": "Humana Inc (HUM) Q2 2026 Earnings Call Highlights: Strategic Exits and Margin Expansion Plans"
              },
              {
                "id": 141055135,
                "url": "https://finnhub.io/api/news?id=4dc12047b41ce397449a1555482561b53f25523ac38d9977a9ca33d8022dc596",
                "image": "https://www.chartmill.com/images/uploads/CM_Unusual_Volume_Small_free_b9d2e60841.webp",
                "source": "ChartMill",
                "related": "HUM",
                "summary": "In today's session, there are S&P500 stocks with remarkable trading volume. Explore the stocks exhibiting unusual volume in Wednesday's session.",
                "category": "company",
                "datetime": 1785344700,
                "headline": "Let's take a look at the S&P500 stocks that are experiencing unusual volume in today's session."
              },
              {
                "id": 141057467,
                "url": "https://finnhub.io/api/news?id=e360f11a86bd99bdfd794672a159e7c2b46b62848aefe150461ba96a55d41f83",
                "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/78567889/image_78567889.jpg?io=getty-c-w1536",
                "source": "SeekingAlpha",
                "related": "HUM",
                "summary": "Humana Inc. aims for a 3% pre-tax margin by 2028 via Medicare Advantage quality and cost cuts. Click for this HUM earnings update.",
                "category": "company",
                "datetime": 1785342262,
                "headline": "Humana Q2 Earnings Review: Management Tight-Lipped, But Recovery Still On Track"
              },
              {
                "id": 141055757,
                "url": "https://finnhub.io/api/news?id=8bab581e89b64142f1da8398b89a2fab0c037087dc924106ed3b864fce3e48e8",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "Q2 Earnings Season in Full Swing",
                "category": "company",
                "datetime": 1785338940,
                "headline": "Q2 Earnings Season in Full Swing"
              },
              {
                "id": 141055751,
                "url": "https://finnhub.io/api/news?id=53d28f66396443a157c170dee0577554538e51740747ecca6013d4ce76ae6b32",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "HUM's Q2 earnings top estimates as medical membership growth, premium gains and CenterWell strength lift results despite higher costs.",
                "category": "company",
                "datetime": 1785338580,
                "headline": "Humana Q2 Earnings Beat Estimates on Medical Membership Growth"
              },
              {
                "id": 141054368,
                "url": "https://finnhub.io/api/news?id=d5e86411c5dc8e9fe060a5ada62808565f4a3ef49be60928ca0102bdd104f86b",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "GE HealthCare Technologies ran at the top of the S&P 500 Wednesday morning, while Humana was among major laggards after both companies posted better-than-expected Q2 earnings signaling a return to profit growth.  GEHC broke above its recent trading range that followed its dive on Q1 results.  Wednesday's stock action was pretty much the reversal of what we've seen this year for GEHC and HUM, with medical equipment stocks among the market's worst-performing industry groups and managed-care stocks ranked in the top tier.",
                "category": "company",
                "datetime": 1785337536,
                "headline": "S&P 500 Stocks: GEHC Revives, Humana Fades On Earnings"
              },
              {
                "id": 141054369,
                "url": "https://finnhub.io/api/news?id=327f060cbb02d4d9d05c91fe2f3acb2cea50a9dac2f2f3785a97470c22f34420",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "A quarter-points rate hike has been bandied about as a possibility today.",
                "category": "company",
                "datetime": 1785336300,
                "headline": "Investors Await Fed Decision Today"
              },
              {
                "id": 141053559,
                "url": "https://finnhub.io/api/news?id=f55fa417a0e86f594f23765075c68cbd56c74801522c2eb9f068e3949fd21792",
                "image": "https://www.chartmill.com/images/uploads/CM_Gap_Stocks_Small_free_ad767b11cf.webp",
                "source": "ChartMill",
                "related": "HUM",
                "summary": "Curious about the market action on Wednesday? Dive into the US markets to explore the gap up and gap down stocks in the S&P500 index during today's session.",
                "category": "company",
                "datetime": 1785335701,
                "headline": "Wednesday's session: gap up and gap down stock in the S&P500 index"
              },
              {
                "id": 141054370,
                "url": "https://finnhub.io/api/news?id=a8d7e4ae03deb08fd5ec2696f8f75246750d42320177e4063bf8b01f39e90bf6",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "While the top- and bottom-line numbers for Humana (HUM) give a sense of how the business performed in the quarter ended June 2026, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.",
                "category": "company",
                "datetime": 1785335402,
                "headline": "Compared to Estimates, Humana (HUM) Q2 Earnings: A Look at Key Metrics"
              },
              {
                "id": 141054371,
                "url": "https://finnhub.io/api/news?id=05f4cfa8318cf163dae3c7ef01b4922555e92af1dc00cb7d556089b208ea179a",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "Humana stock has delivered a powerful run over the past year, yet on the current checks it no longer looks obviously cheap or obviously expensive. The recent share price strength now sits alongside a mixed valuation score and an earnings multiple picture that suggests the market may be close to fair on the stock. Humana has returned 69.5% over the past year, which puts more pressure on today’s buyers to be confident about what they are paying for. Expectations for ongoing healthcare demand...",
                "category": "company",
                "datetime": 1785334135,
                "headline": "Humana (HUM) Stock Looks Fairly Valued Despite Its 70% Run"
              },
              {
                "id": 139799744,
                "url": "https://finnhub.io/api/news?id=ee81d23e3c82c3f8a5ee03d58f0fc4013fe3127fb16979d35a582aaaeee4712c",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "Apple upgraded, Qualcomm downgraded: Wall Street's top analyst calls",
                "category": "company",
                "datetime": 1785332699,
                "headline": "Apple upgraded, Qualcomm downgraded: Wall Street's top analyst calls"
              },
              {
                "id": 141056821,
                "url": "https://finnhub.io/api/news?id=a69ae2fd0894af4bbe9d9da2de7351f66d1698cedc0f51267d81cb7723dc48f7",
                "image": "https://cdn.benzinga.com/files/images/story/2026/07/29/Stuttgart--Germany---07-28-2023-Person-H.jpg?width=2048&height=1536",
                "source": "Benzinga",
                "related": "HUM",
                "summary": "HUM stock drops premarket: Humana beats Q2 estimates, but fails to impress as industry peers raise expectations.",
                "category": "company",
                "datetime": 1785330320,
                "headline": "Humana's Strong Quarter Fails To Impress"
              },
              {
                "id": 141053136,
                "url": "https://finnhub.io/api/news?id=2b9707938c530e89b448569672154c6e44345d1e07aa005c54bd56b843cdfe59",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "The broad market exchange-traded fund SPDR S&P 500 ETF Trust (SPY) was down 0.1%, and the actively t",
                "category": "company",
                "datetime": 1785328722,
                "headline": "Exchange-Traded Funds Lower, Equity Futures Mixed Pre-Bell Wednesday Ahead of Fed's Interest Rate Announcement"
              },
              {
                "id": 141052519,
                "url": "https://finnhub.io/api/news?id=d12ea2b97a7b8de7d8605f8f43bbe2a535312469ed9993773e3e6f01acd75ef9",
                "image": "https://www.chartmill.com/images/uploads/CM_Premarket_Movers_Small_free_90289f6b81.webp",
                "source": "ChartMill",
                "related": "HUM",
                "summary": "The US market is yet to commence its session on Wednesday, but let's get a preview of the pre-market session and explore the top S&P500 gainers and losers driving the early market movements.",
                "category": "company",
                "datetime": 1785328501,
                "headline": "Get insights into the top movers in the S&P500 index of Wednesday's pre-market session."
              },
              {
                "id": 141053214,
                "url": "https://finnhub.io/api/news?id=fb1a6049721baa6d7b46278b6195bd7c00ddf9914757df84a6461b764aaf696d",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "Humana Inc. (NYSE:HUM) shares fell nearly 9% in pre-market trading on Wednesday despite the health insurer reporting second-quarter earnings and revenue that exceeded Wall Street expectations while reaffirming its full-year adjusted earnings guidance.",
                "category": "company",
                "datetime": 1785327467,
                "headline": "Humana Shares Fall Despite Second-Quarter Earnings Beat and Reaffirmed Outlook"
              },
              {
                "id": 141052917,
                "url": "https://finnhub.io/api/news?id=c73ec1e45071df7ab6cf027726410cb65ae0a0f6ec8c56db89e4703ca4176140",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "The main US stock measures were mostly trending higher in Wednesday's premarket activity as traders",
                "category": "company",
                "datetime": 1785326392,
                "headline": "Stocks Mostly Up Pre-Bell Ahead of Fed Rate Decision, Big Tech Earnings"
              },
              {
                "id": 141052233,
                "url": "https://finnhub.io/api/news?id=d0c23ec513b04d1edfd7e0d869fb9785a48fe225b1123f3fb8378e65c864b0f6",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "Health insurance company Humana (NYSE:HUM) announced better-than-expected revenue in Q2 CY2026, with sales up 26.2% year on year to $40.87 billion. Its non-GAAP profit of $7.61 per share was 8.8% above analysts’ consensus estimates.",
                "category": "company",
                "datetime": 1785324849,
                "headline": "Humana (NYSE:HUM) Exceeds Q2 CY2026 Expectations"
              },
              {
                "id": 141053216,
                "url": "https://finnhub.io/api/news?id=5541c542f58c7b5a511ed1cd2bede47c1fed62a45eab3ebb9478b69f6bf2b049",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "Humana (HUM) delivered earnings and revenue surprises of +22.35% and +0.59%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?",
                "category": "company",
                "datetime": 1785324605,
                "headline": "Humana (HUM) Q2 Earnings and Revenues Top Estimates"
              },
              {
                "id": 141051933,
                "url": "https://finnhub.io/api/news?id=0ea0ca902da6eeb86183a85ca1b5803bbb701e70a9cb175e17ed68a94a200af8",
                "image": "https://www.chartmill.com/images/uploads/THUMBNAILS_CHARTMILL_1000_528_17_c249efcc18.webp",
                "source": "ChartMill",
                "related": "HUM",
                "summary": "Humana (HUM) Q2 2026 adjusted EPS beat at $7.61, but revenue slightly missed; stock fell 7% after cutting GAAP outlook while reaffirming adjusted guidance.",
                "category": "company",
                "datetime": 1785324389,
                "headline": "Humana (NYSE:HUM) Slumps After Q2 Beat as GAAP Guidance Cut Overshadows Strong Earnings"
              },
              {
                "id": 141053701,
                "url": "https://finnhub.io/api/news?id=b61af01257df40578b370e166792fdff0584cc566e5915b20839f9da339d8009",
                "image": "https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png",
                "source": "SeekingAlpha",
                "related": "HUM",
                "summary": "Humana Inc. (HUM) Q2 2026 Earnings Call July 29, 2026 8:00 AM EDTCompany ParticipantsLisa Stoner - Vice President of Investor RelationsJames Rechtin -...",
                "category": "company",
                "datetime": 1785323603,
                "headline": "Humana Inc. (HUM) Q2 2026 Earnings Call Transcript"
              },
              {
                "id": 141052234,
                "url": "https://finnhub.io/api/news?id=c28f79576635d146acdf2ddc6e866df7dd2412c0054ac14c5a6cf07e6868071d",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "The health insurer revised its full-year GAAP earnings guidance to at least $6.52 a share, down from at least $8.36",
                "category": "company",
                "datetime": 1785323276,
                "headline": "Humana cuts 2026 profit outlook on lower Medicare star ratings"
              },
              {
                "id": 141052218,
                "url": "https://finnhub.io/api/news?id=eeeb47f4a70334a61d004598296f6ee769f94a81ef86b704a233383585320092",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "LOUISVILLE, Ky., July 29, 2026--Humana Inc. (NYSE: HUM) today announced that the Company’s Board of Directors has elected Paul Smith and Frederick Crawford as new Board members, effective immediately.",
                "category": "company",
                "datetime": 1785322800,
                "headline": "Humana Elects Paul Smith and Frederick Crawford to Board of Directors"
              },
              {
                "id": 141052236,
                "url": "https://finnhub.io/api/news?id=adbeee8812a44cab032bfde8a1fc547f00724c753b082ac4dd02155a3611f09f",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "Investing.com -- Humana Inc. (NYSE: HUM) reported second-quarter earnings before the open on Wednesday, topping consensus expectations.",
                "category": "company",
                "datetime": 1785321954,
                "headline": "Humana falls despite beating second quarter estimates"
              },
              {
                "id": 141052151,
                "url": "https://finnhub.io/api/news?id=f5f80e1ed7da3428606a70bdff1c7fd73533b4a7d1c50efe913c1d9f8efe01c6",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "Humana reports a higher medical cost ratio and reaffirms, rather than raises, its full-year earnings guidance.",
                "category": "company",
                "datetime": 1785320640,
                "headline": "Why Humana Stock Is Falling After Earnings Beat Expectations"
              },
              {
                "id": 141052238,
                "url": "https://finnhub.io/api/news?id=e987c16d3b22ae1c85a61dec113d79add3afc99014e07f573cd79881900d61f8",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "LOUISVILLE, Ky., July 29, 2026--Humana Inc. (NYSE: HUM) today reported consolidated pretax results and diluted earnings per share (EPS) for the quarter ended June 30, 2026 (2Q26) versus the quarter ended June 30, 2025 (2Q25) and for the six months ended June 30, 2026 (YTD 2026) versus the six months ended June 30, 2025 (YTD 2025) as noted in the tables below.",
                "category": "company",
                "datetime": 1785319200,
                "headline": "Humana Reports Second Quarter 2026 Financial Results; Affirms Full Year 2026 Adjusted Financial Guidance"
              },
              {
                "id": 141055320,
                "url": "https://finnhub.io/api/news?id=594083776bc884a7bdb498ebc39608f67adf5e667524d2f304b65f338119eab1",
                "image": "https://image.cnbcfm.com/api/v1/image/108341672-1785328931386-gettyimages-2287298854-img_2575.jpeg?v=1785328962&w=1920&h=1080",
                "source": "CNBC",
                "related": "HUM",
                "summary": "Humana maintained its 2026 adjusted profit outlook of at least $9 per share, which some analysts called a \"disappointment\" amid high expectations for insurers.",
                "category": "company",
                "datetime": 1785317000,
                "headline": "Humana tops quarterly estimates, maintains profit outlook as medical costs stay in line"
              },
              {
                "id": 141051614,
                "url": "https://finnhub.io/api/news?id=49834f02668227a247c046b6c9ef481f8c208ee8172c7929c4e7fd24ef1ea0df",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "Humana (HUM) is back in focus after new research from Humana Healthcare Research on Medicare Advantage selection coincided with rising attention on the company’s upcoming earnings report and its revised profit expectations for the quarter. See our latest analysis for Humana. At a share price of $388.71, Humana has seen strong momentum build, with a 90 day share price return of 59.88% and a 1 year total shareholder return of 69.51%, even though the 3 year and 5 year total shareholder returns...",
                "category": "company",
                "datetime": 1785312604,
                "headline": "Humana (HUM) Could Be 83% Overvalued On Medicare Advantage Study And Earnings Focus"
              },
              {
                "id": 141055946,
                "url": "https://finnhub.io/api/news?id=ef4989b37e96defc10e2b47137708e0d18ad8074a3d1e6861cd983d3f2525106",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "The insurer is laser-focused on reaching margin targets, and will sacrifice some plans with lower returns next year to do so, CFO Celeste Mellet said.",
                "category": "company",
                "datetime": 1785309097,
                "headline": "Humana to exit more Medicare Advantage plans in 2027"
              },
              {
                "id": 141056822,
                "url": "https://finnhub.io/api/news?id=411ceda646fbc52f9f0e20268e25c252d64c39ebc60940bee762e9a29682632e",
                "image": "",
                "source": "Benzinga",
                "related": "HUM",
                "summary": "Humana (NYSE:HUM) FY2026  expected to be more than $6.52 vs $8.55 Est..",
                "category": "company",
                "datetime": 1785304941,
                "headline": "Humana FY2026 GAAP EPS expected to be more than $6.52 vs $8.55 Est"
              },
              {
                "id": 141056823,
                "url": "https://finnhub.io/api/news?id=540e3d8da7c8ed7316c53cfc3e2c13b4407f2b09ba7d82d72b56fb3b7de19053",
                "image": "",
                "source": "Benzinga",
                "related": "HUM",
                "summary": "Humana (NYSE:HUM) FY2026  expected to be more than $9.00 vs $8.94 Est..",
                "category": "company",
                "datetime": 1785304934,
                "headline": "Humana FY2026 Adj EPS expected to be more than $9.00 vs $8.94 Est"
              },
              {
                "id": 141056824,
                "url": "https://finnhub.io/api/news?id=bdcda3e625083cba28d2014f3af49790c2517a82969e62e41f4872c1ffb51e26",
                "image": "https://cdn.benzinga.com/files/images/story/2026/07/29/Stuttgart--Germany---07-28-2023-Person-H.jpg?width=2048&height=1536",
                "source": "Benzinga",
                "related": "HUM",
                "summary": "Humana (HUM) will release Q2 earnings on July 29. Analysts expect $7 EPS and $40.57B revenue. Recent deals and ratings show potential. #HUM",
                "category": "company",
                "datetime": 1785293082,
                "headline": "Humana Gears Up For Q2 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts"
              },
              {
                "id": 141047520,
                "url": "https://finnhub.io/api/news?id=767a0ad3952bb7b868fb1f62d557f9a17b181295616fba5184029f792f9359ee",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "Humana reports earnings Wednesday after its stock surged this year on improving confidence in Medicare Advantage insurers. Investors will be watching medical costs and the company’s outlook.",
                "category": "company",
                "datetime": 1785271080,
                "headline": "Humana Earnings Face High Expectations as Medicare Advantage Recovers"
              },
              {
                "id": 141055210,
                "url": "https://finnhub.io/api/news?id=af225958a6e90dea1bce3e89e151f1d41858e84fc534d0cd99cb597285121846",
                "image": "https://image.cnbcfm.com/api/v1/image/108323516-1785331942032-108323516-1781724683119-gettyimages-2281465619-WARSH_FOMC_NYSE.jpg?v=1785331950&w=1920&h=1080",
                "source": "CNBC",
                "related": "HUM",
                "summary": "The Dow is coming off its third straight winning day.",
                "category": "company",
                "datetime": 1785261759,
                "headline": "Dow falls more than 700 points as oil rises ahead of Fed decision: Live updates"
              },
              {
                "id": 141046976,
                "url": "https://finnhub.io/api/news?id=ee99550e65d283f8fc6944965013ad47621413e2f6544d5e671d18f30d079119",
                "image": "",
                "source": "Benzinga",
                "related": "HUM",
                "summary": "https://www.wsj.com/health/healthcare/trump-administration-to-end-medicare-drug-plan-subsidy-76d255d1",
                "category": "company",
                "datetime": 1785254534,
                "headline": "'Trump Administration To End Medicare Drug Plan Subsidy; Program That Held Down Premiums Not Renewed For 2027, Resulting In Higher Costs For Some Seniors' - WSJ Exclusive"
              },
              {
                "id": 141044040,
                "url": "https://finnhub.io/api/news?id=e2f4b1597f898066a8eadf81dfc30f115dd89681eadb603e194e41f943475a90",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "When a hospital system drops a Medicare Advantage contract, the patient's carefully chosen cardiologist can vanish overnight, and the window to fix it without consequences closes faster than most retirees realize.",
                "category": "company",
                "datetime": 1785251020,
                "headline": "25 Health Systems Have Dropped Medicare Advantage in 2026. Here’s What Enrollees Should Do Now."
              },
              {
                "id": 141042744,
                "url": "https://finnhub.io/api/news?id=2b5d93478a0070b4cfc21b4e019fbf1d6de3c1f4410d61f42b7556f078b93198",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "LOUISVILLE, Ky., July 28, 2026--A new study from Humana Healthcare Research (HHR), published in Health Affairs Scholar, finds that favorable selection in Medicare Advantage (MA) may be significantly lower than commonly cited estimates suggest. Favorable selection refers to the extent to which MA enrollees incur lower costs than predicted after risk adjustment and is an important factor in MA payment policy debates. The study found that a single methodological refinement substantially reduced fav",
                "category": "company",
                "datetime": 1785247200,
                "headline": "New Humana Healthcare Research Study Finds Favorable Selection in Medicare Advantage is Substantially Lower Than MedPAC Estimates"
              },
              {
                "id": 141044041,
                "url": "https://finnhub.io/api/news?id=e9a408c687a9e89d36cd734ac851f3ef74003133d82fad4ebd724d72ba136dcf",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "Looking beyond Wall Street's top-and-bottom-line estimate forecasts for Humana (HUM), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended June 2026.",
                "category": "company",
                "datetime": 1785244508,
                "headline": "Gear Up for Humana (HUM) Q2 Earnings: Wall Street Estimates for Key Metrics"
              },
              {
                "id": 141042745,
                "url": "https://finnhub.io/api/news?id=7244d5ba75603d5242f9e3892bdf072bd65c3db46ea77410b902c33db270ea82",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "Health insurance company Humana (NYSE:HUM) will be announcing earnings results this Wednesday before the bell. Here’s what you need to know.",
                "category": "company",
                "datetime": 1785242222,
                "headline": "Humana (HUM) Reports Q2: Everything You Need To Know Ahead Of Earnings"
              },
              {
                "id": 141042399,
                "url": "https://finnhub.io/api/news?id=636e6876032e77d8e72732ddd75f2acb8ecd9a7d6233a757896254532f03b6d4",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "DENVER, July 28, 2026--As artificial intelligence reshapes cybersecurity, risk management, and enterprise leadership, organizations are looking for practical strategies—not just predictions—to navigate what's next. From November 4-6, more than 700 executive leaders will gather at the Gaylord Rockies Resort & Convention Center in Denver, Colorado, for the EWF Annual Conference.",
                "category": "company",
                "datetime": 1785240000,
                "headline": "As AI Reshapes Cybersecurity, EWF 2026 Brings Together Industry Leaders to Deliver Practical Solutions"
              },
              {
                "id": 141041785,
                "url": "https://finnhub.io/api/news?id=05331852a7fabd0d89cd994e30b93d517cda0768c3cccd460d522c8400fc7c69",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "CVS, CAH, HUM and ACAD show favorable earnings indicators ahead of Q2 results as healthcare demand stays resilient despite margin pressures.",
                "category": "company",
                "datetime": 1785229320,
                "headline": "The Zacks Analyst Blog Highlights CVS Health, Cardinal Health, Humana and ACADIA Pharmaceuticals"
              },
              {
                "id": 141035247,
                "url": "https://finnhub.io/api/news?id=3ce6310c5a7787015ebdff11b4a2487d30095a481eeaf725620e2ed8721805d5",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "CVS, CAH, HUM and ACAD look ready for Q2 2026 earnings beats as growing demand for medical products and services continues to support performance.",
                "category": "company",
                "datetime": 1785168180,
                "headline": "4 Medical Stocks With the Right Setup for Q2 Earnings Beats"
              },
              {
                "id": 141036164,
                "url": "https://finnhub.io/api/news?id=a6b6c6d4c90a0bb74ebbcd36a3334c681541ab8ecc3c1dd3fb8a84bf94227e17",
                "image": "https://cdn.benzinga.com/files/images/story/2025/11/06/aggregated_options_2.jpg?width=2048&height=1536",
                "source": "Benzinga",
                "related": "HUM",
                "summary": "This whale alert can help traders discover the next big trading opportunities.\nWhales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scanner.\nTraders will",
                "category": "company",
                "datetime": 1785159309,
                "headline": "4 Health Care Stocks Whale Activity In Today’s Session"
              },
              {
                "id": 141053131,
                "url": "https://finnhub.io/api/news?id=7043adeae041cf21f37d02e1bb6cd835bc9ea1447c64a086dfc789612b0beffe",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "Earnings season kicks into high gear this week.",
                "category": "company",
                "datetime": 1785153127,
                "headline": "Earnings live: Humana stock falls, Procter & Gamble dips, with Big Tech earnings on deck"
              },
              {
                "id": 141024010,
                "url": "https://finnhub.io/api/news?id=2c5db92c8ab827ee6f3b90cbf33fde6ea6c56be2eb02d39168027e8407bb46f0",
                "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/803420378/image_803420378.jpg?io=getty-c-w1536",
                "source": "SeekingAlpha",
                "related": "HUM",
                "summary": "The series targets generating 12–15% annualized income through disciplined selling of PUT and BUY-WRITE CALL options on large-cap stocks. Check out the strategy here.",
                "category": "company",
                "datetime": 1785053700,
                "headline": "Earn 10-15% Potential Income: Monthly Options Series (Aug. 2026)"
              },
              {
                "id": 141010762,
                "url": "https://finnhub.io/api/news?id=34cf0495c3aad32ad59c71b73880c9d0cf75062d6a008f74ecd1fff6c757b090",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "The healthcare giant looks expensive on today's numbers, but a patient investor is effectively buying it at a significant discount to that price.",
                "category": "company",
                "datetime": 1784926584,
                "headline": "The Real Price of UnitedHealth Stock Is Two Years Away"
              },
              {
                "id": 141007777,
                "url": "https://finnhub.io/api/news?id=ec70fca7d4366d7d7666d1585311865e707df9f66c2e2a1ea1135a70b6f4f642",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "HUM enters Q2 earnings with strong premium and membership growth expectations, but rising medical costs and expenses could test its bottom line.",
                "category": "company",
                "datetime": 1784911140,
                "headline": "Can Humana Beat Q2 Earnings Estimates on Growing Premiums?"
              }
            ],
            "data_source": "finnhub_news_keyword_model",
            "article_count": 8,
            "negative_hits": 0,
            "positive_hits": 3,
            "recomputed_at_score": true,
            "sentiment_score_raw": 0.9,
            "source_article_count": 122,
            "discarded_article_count": 99
          },
          "sentimentPoints": 4
        }
      },
      "技術信號": {
        "max": 30,
        "raw": 17.7,
        "grade": "較差",
        "items": {
          "bbPoints": 3,
          "adxPoints": 3,
          "sarPoints": 2.4000000000000004,
          "vcpPoints": 2.2,
          "macdPoints": 2.4,
          "vcpPayload": {
            "vcp_pass": false,
            "vcp_score": 2.2,
            "vcp_reason": "波幅收縮(19.8%→7.8%)；跌縮量(近10日5日)；靠近20日高位；Ready=Y；Confirm=N",
            "vcp_metrics": {
              "up_days": 4,
              "vol_ref": 1386063.3333333333,
              "down_days": 5,
              "vcp_ready": true,
              "above_ma50": false,
              "avg_vol_10": 1001790,
              "avg_vol_20": 1405920,
              "avg_vol_30": 1386063.3333333333,
              "range_pct_10": 0.07838896220439194,
              "range_pct_20": 0.1211992979307432,
              "range_pct_30": 0.19845333614864866,
              "up_expand_ok": false,
              "lookback_used": 59,
              "near_20d_high": true,
              "contraction_ok": true,
              "down_shrink_ok": true,
              "up_expand_days": 0,
              "breakout_20d_ok": false,
              "vol_ratio_10_30": 0.7227591812783928,
              "dist_to_20d_high": 0.051875554962977743,
              "down_shrink_days": 5,
              "breakout_level_20d": 399.60999,
              "vcp_breakout_confirm": false,
              "contraction_ratio_10_30": 0.39499946801436386
            },
            "vcp_name_en": "Volatility Contraction Pattern",
            "vcp_name_zh": "波動收縮形態",
            "vol_contraction": true
          },
          "kdjAdxPoints": 0.5,
          "rsiKdjPoints": 2.4,
          "volumeWeight": 2,
          "maCrossPoints": 0,
          "shortRsiPoints": 0,
          "shortMacdPoints": 0.4,
          "volConfirmPoints": 0.6,
          "volumePointsTechnical": 0.8
        }
      },
      "風險管理": {
        "max": 10,
        "grade": "較差",
        "items": {
          "position": {
            "score": 1.3,
            "details": {
              "atrPct": 3.570682010135135,
              "turnoverUsdM": 433.287168,
              "liquidityPoints": 0.6,
              "volatilityPoints": 0.7
            }
          },
          "rrPoints": 1.4,
          "stopLevels": {
            "symbol": "US.HUM",
            "rr_range": "1:1.0-1:2.5",
            "risk_profile": "中等",
            "stop_loss_price": 351.8228,
            "strength_details": {
              "ma_score": 1,
              "atr_score": 1,
              "rsi_score": 2,
              "macd_score": 1.5,
              "volume_score": 1
            },
            "market_adjustment": 1,
            "risk_reward_ratio": 1,
            "stop_loss_percent": 7.1,
            "take_profit_price": 398.0004,
            "target_multiplier": 1.6,
            "technical_strength": 1.33,
            "take_profit_percent": 5
          },
          "positionPoints": 1.3,
          "stopLossPoints": 1.2,
          "diversification": {
            "score": 2,
            "details": {
              "method": "sector concentration proxy; no portfolio holdings used",
              "sector": "Health Care",
              "concentratedSectorPenalty": 0
            }
          },
          "riskRewardRatio": 1.2,
          "stopLossPercent": 7.14136402027027,
          "diversificationPoints": 2
        }
      }
    }
  },
  "modelVersion": "cursor_18_27_news_v2_160",
  "providerErrors": [],
  "rankingScoreMax": 160,
  "dataCompleteness": {
    "complete": true,
    "missingFields": [],
    "optionalInputs": [
      "institutionalData"
    ],
    "requiredInputs": [
      "fundamentals",
      "marketContext.VIX",
      "marketContext.SPY",
      "marketContext.QQQ",
      "catalystData",
      "sentimentData",
      "ATR",
      "sector"
    ],
    "optionalInputWarnings": []
  },
  "technicalIndicators": {
    "adx": 100,
    "atr": {
      "atr": 13.5286,
      "rule": "ATR / current price; lower volatility scores higher",
      "score": 4,
      "atr_pct": 3.57
    },
    "cci": {
      "rule": "Cursor_18.24 CCI bands",
      "level": "平衡",
      "score": 6,
      "value": 42
    },
    "cmf": {
      "rule": "Cursor_18.24 CMF bands",
      "level": "派發",
      "score": 2,
      "value": -0.0184
    },
    "kdj": {
      "d": 60.42,
      "j": 34.3,
      "k": 51.71,
      "rule": "Cursor_18.24 K/D cross",
      "score": 0,
      "signal": "死叉"
    },
    "mfi": {
      "rule": "Cursor_18.24 MFI bands",
      "level": "平衡",
      "score": 6,
      "value": 59.12
    },
    "obv": {
      "rule": "Cursor_18.24 recent_slope vs previous_slope",
      "score": 4,
      "trend": "弱勢",
      "value": 14263800,
      "recentSlope": -193330,
      "previousSlope": 431740
    },
    "rsi": 52.48,
    "sar": {
      "rule": "Cursor_18.24 Parabolic SAR",
      "score": 8,
      "trend": "上升",
      "value": 366.3669,
      "position": "SAR喺價下",
      "distancePct": 3.3,
      "previousTrend": "上升"
    },
    "ma50": 383.2498,
    "macd": {
      "macd": 0.16998442409641257,
      "trend": "中性偏多",
      "signal": 0.19731537705253843,
      "histogram": -0.027330952956125865
    },
    "vwap": {
      "rule": "Cursor_18.24 VWAP 20D consecutive close",
      "score": 10,
      "value": 375.4585,
      "position": "連續5日>VWAP",
      "consecutiveAbove": 8
    },
    "volume": {
      "rule": "Cursor_18.24 volume ratio",
      "level": "無力",
      "ratio": 0.8,
      "score": 4,
      "avgVolume": 1426085,
      "currentVolume": 1143600
    },
    "derived": {
      "ma20": 377.191,
      "ma50": 383.2498,
      "prevClose": 380.73,
      "avgVolume10": 975650,
      "avgVolume20": 1426085,
      "changePercent": -0.49,
      "avgVolumeForScore": 1426085
    },
    "ma_cross": {
      "ma20": 377.191,
      "ma50": 383.2498,
      "rule": "Cursor_18.24 MA20/MA50 cross",
      "cross": "熊勢",
      "score": 0,
      "prevMa20": 377.713,
      "prevMa50": 382.9614,
      "spreadPct": 1.58,
      "isVolumeBreakout": false
    },
    "bollinger": {
      "lower": 358.9387,
      "upper": 395.4433,
      "position": "上半部"
    },
    "rsi_short": 34.52,
    "macd_short": {
      "macd": 0,
      "trend": "中性",
      "signal": 0,
      "histogram": 0
    },
    "volume_ratio": {
      "ratio": 0.8
    }
  }
}

{
  "close": 378.88,
  "volume": 1143600,
  "changePercent": -0.49
}